# T3D Therapeutics, Inc.: funding, NIH (2023)

Registers read on November 19, 2026.

T3D Therapeutics, Inc. (North Carolina) appears in 2 public registers SpecStream reads: 8 Form D filings and 3 NIH and NSF awards; the newest record is dated August 15, 2023, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 2
- Newest record: August 15, 2023
- State: North Carolina

## Form D filings (SEC)

8 Form D filings, newest September 6, 2022.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/t3d-therapeutics-inc-1579600) | September 6, 2022 | $6 million sold of $7.5 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960022000001/0001579600-22-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/t3d-therapeutics-inc-1579600) | November 1, 2019 | $15 million sold of $15 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960019000001/0001579600-19-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/t3d-therapeutics-inc-1579600) | March 12, 2018 | $6 million sold of $18 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960018000002/0001579600-18-000002-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/t3d-therapeutics-inc-1579600) | January 12, 2018 | $711.3 thousand sold of $1 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960018000001/0001579600-18-000001-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/t3d-therapeutics-inc-1579600) | March 14, 2016 | $1.2 million sold of $3.8 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960016000002/0001579600-16-000002-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/t3d-therapeutics-inc-1579600) | March 13, 2015 | $115 thousand sold of $3 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960015000001/0001579600-15-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/t3d-therapeutics-inc-1579600) | March 14, 2014 | $661 thousand sold of $2.5 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960014000001/0001579600-14-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/t3d-therapeutics-inc-1579600) | August 5, 2013 | $437 thousand sold of $550 thousand offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1579600/000157960013000002/0001579600-13-000002-index.htm) |

- [T3D Therapeutics, Inc.](https://specstream.ai/data/form-d/company/t3d-therapeutics-inc-1579600)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1579600&type=D)

## NIH and NSF research awards

3 NIH and NSF awards, newest August 15, 2023.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [NIH](https://specstream.ai/data/research-funding/organization/t3d-therapeutics-inc-nnguw8xdl245) | August 15, 2023 | Clinical Development Enablement – Long Term Rodent Testing of the Carcinogenic Potential of the Alzheimer’s Disease Drug Candidate T3D-959 | [reporter.nih.gov](https://reporter.nih.gov/project-details/11091651) |
| [NIH](https://specstream.ai/data/research-funding/organization/t3d-therapeutics-inc-nnguw8xdl245) | September 21, 2022 | Phase 2 Enabling Studies of a Candidate Drug Therapy (T3D-959) Regulating Neurometabolism for the Treatment of Huntington's Disease; $1.6 | [reporter.nih.gov](https://reporter.nih.gov/project-details/10708865) |
| [NIH](https://specstream.ai/data/research-funding/organization/t3d-therapeutics-inc-nnguw8xdl245) | May 1, 2019 | Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects; $12.6 | [reporter.nih.gov](https://reporter.nih.gov/project-details/10444130) |

- [T3D Therapeutics, Inc.](https://specstream.ai/data/research-funding/organization/t3d-therapeutics-inc-nnguw8xdl245)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (North Carolina), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in North Carolina

- [Insulation contractors in North Carolina, United States](https://specstream.ai/data/businesses/insulation-contractors/north-carolina-united-states)
- [IT companies in North Carolina, United States](https://specstream.ai/data/businesses/it-companies/north-carolina-united-states)
- [Junk removal companies in North Carolina, United States](https://specstream.ai/data/businesses/junk-removal-companies/north-carolina-united-states)
- [Latin American restaurants in North Carolina, United States](https://specstream.ai/data/businesses/latin-american-restaurants/north-carolina-united-states)
- [Machine shops in North Carolina, United States](https://specstream.ai/data/businesses/machine-shops/north-carolina-united-states)
- [Medical billing companies in North Carolina, United States](https://specstream.ai/data/businesses/medical-billing-companies/north-carolina-united-states)
